Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;86(3):1415-1426.
doi: 10.3233/JAD-215267.

Association Between Late-Life Neuropsychiatric Symptoms and Cognitive Decline in Relation to White Matter Hyperintensities and Amyloid Burden

Carol K Chan  1 , Corinne Pettigrew  2 , Anja Soldan  2 , Yuxin Zhu  2   3 , Mei-Cheng Wang  4 , Marilyn Albert  2 , Paul B Rosenberg  1 ; BIOCARD Research Team
Affiliations

Association Between Late-Life Neuropsychiatric Symptoms and Cognitive Decline in Relation to White Matter Hyperintensities and Amyloid Burden

Carol K Chan et al. J Alzheimers Dis. 2022.

Abstract

Background: Neuropsychiatric symptoms (NPS) among cognitively normal older adults are increasingly recognized as risk factors for cognitive decline and impairment. However, the underlying mechanisms remain unclear.

Objective: To examine whether biomarkers of Alzheimer's disease (amyloid burden) and cerebrovascular disease (white matter hyperintensity (WMH) volume) modify the association between NPS and cognitive decline among cognitively unimpaired older adults.

Methods: Analyses included 193 cognitively unimpaired participants (M age = 70 years) from the BIOCARD study, including 148 with PET amyloid and WMH biomarker data. NPS were measured with Neuropsychiatric Inventory and Geriatric Depression Scale scores. Linear mixed effects models were used to examine the association between baseline NPS and longitudinal cognitive trajectories (M follow-up = 3.05 years), using separate models for global, episodic memory, and executive function cognitive composite scores. In a subset of individuals with biomarker data, we evaluated whether WMH or cortical amyloid burden modified the relationship between NPS and cognitive change (as indicated by the NPS×biomarker×time interactions).

Results: Higher baseline NPS were associated with lower executive function scores, but not a faster rate of decline in executive function. NPS symptoms were unrelated to the global or episodic memory composite scores, and there was little evidence of a relationship between NPS symptoms and cognitive change over time. The associations between NPS and cognitive decline did not differ by amyloid or WMH burden, and NPS were unrelated to amyloid and WMH burden.

Conclusion: These results suggest that the effect of neuropsychiatric symptoms on executive dysfunction may occur through mechanisms outside of amyloid and cerebrovascular disease.

Keywords: Alzheimer’s disease; amyloid; depression; mild behavioral impairment; neuropsychiatric symptoms; white matter hyperintensities.

PubMed Disclaimer

References

    1. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B (2006) Mild cognitive impairment. Lancet 367, 1262–1270. - PubMed
    1. Banks SJ, Raman R, He F, Salmon DP, Ferris S, Aisen P, Cummings J (2014) The Alzheimer’s disease cooperative study prevention instrument project: Longitudinal outcome of behavioral measures as predictors of cognitive decline. Dement Geriatr Cogn Dis Extra 4, 509–516. - PMC - PubMed
    1. Geda YE, Roberts RO, Mielke MM, Knopman DS, Christianson TJH, Pankratz VS, Boeve BF, Sochor O, Tangalos EG, Petersen RC, Rocca WA (2014) Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: A population-based study. AJP 171, 572–581. - PMC - PubMed
    1. Leoutsakos JS, Forrester SN, Corcoran CD, Norton MC, Rabins PV, Steinberg MI, Tschanz JT, Lyketsos CG (2015) Latent classes of course in Alzheimer’s disease and predictors: The Cache County Dementia Progression Study. Int J Geriatr Psychiatry 30, 824–832. - PMC - PubMed
    1. Masters MC, Morris JC, Roe CM (2015) “Noncognitive” symptoms of early Alzheimer disease: A longitudinal analysis. Neurology 84, 617–622. - PMC - PubMed

Publication types